Literature DB >> 28361083

Next steps to improve disparities in lung cancer treatment clinical trial enrollment.

Leah L Zullig1, William R Carpenter2, Christina D Williams3.   

Abstract

Entities:  

Year:  2017        PMID： 28361083      PMCID： PMC5360614          DOI： 10.21037/atm.2017.01.25

Source DB:  PubMed          Journal:  Ann Transl Med        ISSN： 2305-5839


× No keyword cloud information.
  13 in total

Review 1.  Translating research into evidence-based practice: the National Cancer Institute Community Clinical Oncology Program.

Authors:  Lori M Minasian; William R Carpenter; Bryan J Weiner; Darrell E Anderson; Worta McCaskill-Stevens; Stefanie Nelson; Cynthia Whitman; Joseph Kelaghan; Ann M O'Mara; Arnold D Kaluzny
Journal:  Cancer       Date:  2010-10-01       Impact factor: 6.860

2.  How representative are the surveillance, epidemiology, and end results (SEER) program cancer data of the United States?

Authors:  Ray M Merrill; Kirk A Dearden
Journal:  Cancer Causes Control       Date:  2004-12       Impact factor: 2.506

3.  Enrollment Trends and Disparity Among Patients With Lung Cancer in National Clinical Trials, 1990 to 2012.

Authors:  Herbert H Pang; Xiaofei Wang; Thomas E Stinchcombe; Melisa L Wong; Perry Cheng; Apar Kishor Ganti; Daniel J Sargent; Ying Zhang; Chen Hu; Sumithra J Mandrekar; Mary W Redman; Judith B Manola; Richard L Schilsky; Harvey J Cohen; Jeffrey D Bradley; Alex A Adjei; David Gandara; Suresh S Ramalingam; Everett E Vokes
Journal:  J Clin Oncol       Date:  2016-09-30       Impact factor: 44.544

4.  A framework for understanding cancer comparative effectiveness research data needs.

Authors:  William R Carpenter; Anne-Marie Meyer; Amy P Abernethy; Til Stürmer; Michael R Kosorok
Journal:  J Clin Epidemiol       Date:  2012-11       Impact factor: 6.437

5.  Enrollment in clinical trials according to patients race: experience from the VA Cooperative Studies Program (1975-2000).

Authors:  Eugene Z Oddone; Maren K Olsen; Jennifer Hoff Lindquist; Melinda Orr; Ronnie Horner; Domenic Reda; Philip Lavori; Gary Johnson; Joseph Collins; John R Feussner
Journal:  Control Clin Trials       Date:  2004-08

6.  Clinical trial spots for cancer patients by tumour type: The cancer trials portfolio at clinicaltrials.gov.

Authors:  Vinay Prasad; Jeffery A Goldstein
Journal:  Eur J Cancer       Date:  2015-08-25       Impact factor: 9.162

7.  Cancer statistics, 2016.

Authors:  Rebecca L Siegel; Kimberly D Miller; Ahmedin Jemal
Journal:  CA Cancer J Clin       Date:  2016-01-07       Impact factor: 508.702

8.  Participation in cancer clinical trials: race-, sex-, and age-based disparities.

Authors:  Vivek H Murthy; Harlan M Krumholz; Cary P Gross
Journal:  JAMA       Date:  2004-06-09       Impact factor: 56.272

9.  Enrollment and Racial Disparities in Cancer Treatment Clinical Trials in North Carolina.

Authors:  Leah L Zullig; Alice G Fortune-Britt; Shangbang Rao; Seth D Tyree; Paul A Godley; William R Carpenter
Journal:  N C Med J       Date:  2016 Jan-Feb

10.  Diversity in Clinical and Biomedical Research: A Promise Yet to Be Fulfilled.

Authors:  Sam S Oh; Joshua Galanter; Neeta Thakur; Maria Pino-Yanes; Nicolas E Barcelo; Marquitta J White; Danielle M de Bruin; Ruth M Greenblatt; Kirsten Bibbins-Domingo; Alan H B Wu; Luisa N Borrell; Chris Gunter; Neil R Powe; Esteban G Burchard
Journal:  PLoS Med       Date:  2015-12-15       Impact factor: 11.069
View more
  1 in total

1.  Association of Broad-Based Genomic Sequencing With Survival Among Patients With Advanced Non-Small Cell Lung Cancer in the Community Oncology Setting.

Authors:  Carolyn J Presley; Daiwei Tang; Pamela R Soulos; Anne C Chiang; Janina A Longtine; Kerin B Adelson; Roy S Herbst; Weiwei Zhu; Nathan C Nussbaum; Rachael A Sorg; Vineeta Agarwala; Amy P Abernethy; Cary P Gross
Journal:  JAMA       Date:  2018-08-07       Impact factor: 56.272
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.